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حالة داء النشوائي العقيدي الرئوي مشاهبا للعقيدات الرئوية السرطانية
تقرير حالة و استعراض األدبيات العلمية
را�شد العمريي، فاطمة اللواتية، ف�شيلة حممد البو�شعيدية 
abstract: Amyloidosis is a disorder characterised by the extracellular deposition of amyloid, a fibrillary protein, 
in various organs such as the lungs. Pulmonary nodular amyloidosis can mimic other lung conditions that present 
with pulmonary nodules, such as metastasis, sarcoidosis and hyalinising granuloma. We report a 60-year-old man 
who presented to the Royal Hospital, Muscat, Oman, in 2017 with a history of shortness of breath upon exertion, 
orthopnoea and bilateral lower limb swelling. A chest X-ray showed bilateral nodular opacities. Enhanced chest 
computed tomography revealed bilateral pulmonary nodules with a predominantly perilymphatic and subpleural 
distribution, giving the impression of a neoplastic nodule. A histopathological examination of biopsied lung tissue 
confirmed a diagnosis of nodular pulmonary amyloidosis.
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)الأميلويد، بروتني ليفي( خارج ج�شم اخللية يف  الن�شا  )الأميلويد( هو حالة مر�شية تت�شف برت�شب مادة �شبيهة  الن�شواين  داء  امللخ�ص: 
اأع�شاء خمتلفة من ج�شم الأن�شان مبا يف ذلك الرئتني، داء الن�شواين العقيدي الرئوي قد ي�شابه اأمرا�شًا وحالت رئوية اأخرى تت�شف بظهور 
عقيدات رئوية، ومن هذه احلالت العقيدات ال�رسطانية اخلبيثة املنتقلة من ع�شو اآخر، وت�شخم ال�شاركويد والورم احلبيبي ال�شفاف، نعر�ص 
هنا حالة لرجل يبلغ من العمر 60 عامًا مت معاينته يف امل�شت�شفى ال�شلطاين يف م�شقط ب�شلطنة عمان يف عام 2017، وكان يعاين من �شيق 
يف التنف�ص عند بذل جمهود وعند ال�شطجاع وكذلك من انتفاخ يف القدمني، وقد اأظهرت ال�شعة ال�شينية لل�شدر وجود عقيدات يف كلتا 
الرئتني، ملعرفة املزيد عن طبيعة هذه العقيدات الرئوية مت اإجراء اإ�شعة مقطعية مع ا�شتخدام �شبغة عن طريق الوريد والتي او�شحت وجود 
عقيدات رئوية تتوزع ب�شكل ملحوظ يف حميط الأوعية اللمفاوية وحتت اجلنبة، اأعطت هذه العقيدات ا�شتباهًا باأنها متثل اأورامًا �رسطانية، 
اإل اأن الفح�ص املجهري الن�شيجي لعينة اأخذت من الرئة اأكدت ت�شخي�ص داء الن�شواين )الأميلويد( الرئوي العقيدي.
الكلمات املفتاحية: عقيدات رئوية متعددة؛ داء الن�شواين )الأميلويد(؛ اأ�شعة مقطعية؛ تقرير حالة؛ عمان.
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Amyloidosis is a disorder resulting from the abnormal extracellular accumulation of amy-loid in various tissues and organs.1 Amyloidosis 
can be primary (i.e. idiopathic) or, more commonly, sec- 
ondary to a variety of pathological conditions, including 
neoplastic, infectious and inflammatory aetiologies.2–4 
Pulmonary amyloidosis may be part of a systemic process 
or confined only to the lung, at which point it is classified 
as tracheobronchial, parenchymal nodular or diffuse 
alveolar septal pulmonary amyloidosis.5,6 Although rare, 
nodular pulmonary amyloidosis can mimic other, more 
common, pulmonary disorders that manifest as multiple 
pulmonary masses or nodules, such as neoplastic and 
granulomatous conditions.2,7,8 Therefore, pulmonary amy-
loidosis should be included in the differential diagnosis 
of single or multiple pulmonary nodules.
Case Report 
A 60-year-old man presented to the Emergency Depart- 
ment of the Royal Hospital, Muscat, Oman, in 2017 with 
a recent history of shortness of breath upon exertion, 
orthopnoea and bilateral lower limb swelling. He was 
an ex-smoker, diabetic and was currently taking insulin. 
There was no history of fever or chest pain, although 
he had dilated cardiomyopathy with a left ventricle 
ejection fraction of 35%. Upon physical examination, 
there were bilateral chest crepitations and bilateral 
lower limb oedema. All vital signs and other systemic 
examinations were unremarkable. A complete blood 
count, erythrocyte sedimentation rate, C-reactive protein 
level and renal and liver function tests were within 
normal limits.
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The patient subsequently underwent a chest X-ray 
which showed bilateral nodular opacities [Figure 1]. 
Further evaluation using enhanced computed tomo-
graphy (CT) revealed bilateral pulmonary nodules with 
a predominantly perilymphatic and subpleural distrib- 
ution. The largest nodule arose in the right upper lobe, 
abutting the fissure, and measured 2.3 × 2.9 cm. There 
was no evidence of pleural effusion or enlargement of 
the lymph nodes, although some of the nodules showed 
central calcification [Figure 2]. The preliminary diagnosis 
was of a neoplastic nodule that required further invest- 
igation. Accordingly, CT scans of the abdomen and pelvis 
were performed; however, the findings were unrem-
arkable.
A tissue biopsy from the lung nodules was obtained 
under CT guidance. A microscopic examination of the 
tissue sample showed cores of hyalinised tissue with 
foci of haemorrhage. A haematoxylin and eosin stain 
showed deposits of eosinophilic amorphous material 
[Figure 3]. A special stain with Congo red and thioflavin 
T dyes revealed deposition of amyloid fibrils, consistent 
with a histological diagnosis of amyloidosis. As the patient 
was asymptomatic and there were no features suggestive 
of systemic amyloidosis, the decision was made to keep 
the patient under regular follow-up and observation. 
Discussion
Amyloidosis has an estimated global incidence of approx- 
imately 10 cases per million patients each year.9 To 
the best of the authors’ knowledge, the present case is 
the first to be reported from Oman. According to the 
site of deposition, amyloidosis can be categorised as 
systemic or localised. The four subtypes of systemic 
amyloidosis are primary light-chain amyloidosis, sec-
ondary amyloid A amyloidosis, familial amyloidosis 
and β2-microglobulin-related amyloidosis.10 The most 
common is secondary amyloid A amyloidosis, resulting 
from deposited amyloid P component. It mainly occurs 
in patients with chronic infections and those with rheum- 
atic or autoimmune diseases.1,2 In contrast, primary light- 
chain amyloidosis is due to deposited kappa and lambda 
light chains and can be associated with multiple myeloma, 
Waldenström’s macroglobulinaemia and asymptomatic 
monoclonal gammopathy.1
Isolated pulmonary amyloidosis is rare and can be 
categorised into tracheobronchial, parenchymal nodular 
and diffuse alveolar septal amyloidosis.5,6 Hui et al. rep- 
orted 48 patients with localised respiratory amyloidosis, of 
which 14 had tracheobronchial amyloidosis, 28 showed 
either solitary or multiple pulmonary nodules and six 
had a diffuse interstitial parenchymal pattern.11 Most of the 
 
Figure 1: Chest X-ray of a 60-year-old man with shortness 
of breath upon exertion, orthopnoea and bilateral lower 
limb oedema showing several nodular opacities (arrows), 
predominantly in the right lung.
 
Figure 3: Haematoxylin and eosin stain at x10 magnif-
ication showing eosinophilic and amorphous material 
deposits (arrows).
 
Figure 2: High-resolution chest computed tomography 
scans in the (A & B) axial and (C & D) coronal views of a 
60-year-old man with shortness of breath upon exertion, 
orthopnoea and bilateral lower limb oedema showing 
bilateral pulmonary nodules (arrows) with central calcif- 
ication of the right upper nodule (arrowhead).
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red staining, the amyloid proteins display green bire-
fringence under polarised light.2,3,9,12
Due to the rarity of the condition, no randomised 
controlled trials have yet been conducted regarding 
nodular pulmonary amyloidosis management. However, 
the general consensus is that treatment depends on 
the severity of the symptoms. For example, for asympt- 
omatic patients, regular follow-up and careful monitoring 
may be sufficient.2 In contrast, different treatment 
options may be necessary for symptomatic patients, 
including conservative excision, carbon dioxide laser 
ablation and low-dose external beam radiation.9,18
Conclusion
Nodular pulmonary amyloidosis is a rare and usually 
localised disease that can mimic other nodular pulmonary 
disorders, such as neoplastic and granulomatous pro-
cesses. As such, this condition should be included in the 
differential diagnosis of pulmonary nodules or masses.
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